135 related articles for article (PubMed ID: 33659408)
1. Screening Method for CRISPR/Cas9 Inhibition of a Human DNA Virus: Herpes Simplex Virus.
Neuhausser WM; Oh HS; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
Bio Protoc; 2020 Sep; 10(17):e3748. PubMed ID: 33659408
[TBL] [Abstract][Full Text] [Related]
2. Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions.
Xu H; Wang J; Deng Y; Hou F; Fu Y; Chen S; Zou W; Pan D; Chen B
J Virol; 2022 Dec; 96(24):e0092022. PubMed ID: 36453882
[TBL] [Abstract][Full Text] [Related]
3. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
[TBL] [Abstract][Full Text] [Related]
4. Developing oncolytic
Ebrahimi S; Makvandi M; Abbasi S; Azadmanesh K; Teimoori A
Iran J Basic Med Sci; 2020 Jul; 23(7):937-944. PubMed ID: 32774817
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of herpes simplex virus infections: past, present, and future.
Whitley R; Baines J
F1000Res; 2018; 7():. PubMed ID: 30443341
[TBL] [Abstract][Full Text] [Related]
7. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
Chen YC; Sheng J; Trang P; Liu F
Viruses; 2018 May; 10(6):. PubMed ID: 29844277
[TBL] [Abstract][Full Text] [Related]
8. Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases.
Russell TA; Stefanovic T; Tscharke DC
J Virol Methods; 2015 Mar; 213():18-25. PubMed ID: 25479355
[TBL] [Abstract][Full Text] [Related]
9. CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9.
Ying M; Wang H; Liu T; Han Z; Lin K; Shi Q; Zheng N; Ye T; Gong H; Xu F
Pathogens; 2023 Jun; 12(6):. PubMed ID: 37375504
[TBL] [Abstract][Full Text] [Related]
10. Herpes Simplex Virus 1 Strains 17
Grams TR; Edwards TG; Bloom DC
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461310
[TBL] [Abstract][Full Text] [Related]
11. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
Kennedy EM; Cullen BR
Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
[TBL] [Abstract][Full Text] [Related]
12. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
[TBL] [Abstract][Full Text] [Related]
13. CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection.
Lee JS; Raja P; Pan D; Pesola JM; Coen DM; Knipe DM
mBio; 2018 Feb; 9(1):. PubMed ID: 29437926
[TBL] [Abstract][Full Text] [Related]
14. Erratum: CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy.
J Vis Exp; 2021 Mar; (169):. PubMed ID: 33690264
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 Mutagenesis of UL21 in Multiple Strains of Herpes Simplex Virus Reveals Differential Requirements for pUL21 in Viral Replication.
Finnen RL; Banfield BW
Viruses; 2018 May; 10(5):. PubMed ID: 29762484
[TBL] [Abstract][Full Text] [Related]
16. Herpes Simplex Virus 1 Manipulates Host Cell Antiviral and Proviral DNA Damage Responses.
Mertens ME; Knipe DM
mBio; 2021 Feb; 12(1):. PubMed ID: 33563816
[TBL] [Abstract][Full Text] [Related]
17. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
Zhang I; Hsiao Z; Liu F
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
[TBL] [Abstract][Full Text] [Related]
18. An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.
Thellman NM; Botting C; Madaj Z; Triezenberg SJ
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404842
[TBL] [Abstract][Full Text] [Related]
19. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
20. Herpes Simplex Virus 1 Lytic Infection Blocks MicroRNA (miRNA) Biogenesis at the Stage of Nuclear Export of Pre-miRNAs.
Pan D; Li G; Morris-Love J; Qi S; Feng L; Mertens ME; Jurak I; Knipe DM; Coen DM
mBio; 2019 Feb; 10(1):. PubMed ID: 30755517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
